Live
- BJP flags plight of primary school
- Sensex surges 855 pts despite geo-political tensions, PSU bank stocks shine
- ED likely to question some Dubai-based Indians in Bengal ration scam case
- Minor quake hits Manipur's Bishnupur district
- BJP's Bihar leaders huddle at Union Minister Giriraj Singh's Delhi residence
- 10 Maoists gunned down in encounter with security forces in Sukma
- K’taka parties keenly await bypoll results, spotlight on high-profile Channapatna
- Hyderabad Student Aryan Reddy Dies in Tragic Gun Misfire Accident on His Birthday in Atlanta
- Iraqi PM, Putin discuss regional situation, energy cooperation over phone
- Pushpa 2 Shooting Still Pending? Will It Release on Time?
Misleading ads case: Patanjali tells SC that it has withdrawn sales and advertisements of banned products
Patanjali Ayurved on Tuesday apprised the Supreme Court that it has withdrawn the sale and advertisements of products whose manufacturing licenses were suspended by the Uttarakhand State Licencing Authority in April this year.
New Delhi : Patanjali Ayurved on Tuesday apprised the Supreme Court that it has withdrawn the sale and advertisements of products whose manufacturing licenses were suspended by the Uttarakhand State Licencing Authority in April this year.
A bench, headed by Justice Hima Kohli, was hearing a plea filed by the Indian Medical Association seeking action against Patanjali for violation of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 – which prohibits the advertisement of certain products for the treatment of specified diseases and disorders, including diabetes, heart diseases, high or low blood pressure and obesity.
Earlier, the top court had questioned senior advocate Balbir Singh, representing Patanjali, about the continued presence of misleading ads, particularly on social media platforms.
In an affidavit filed before the apex court in April this year, the Uttarakhand government said that it has granted permission to file a complaint against Ramdev's Divya Pharmacy and Patanjali Ayurved Ltd. for repeated violations of the drug advertisements law and suspended manufacturing licenses for 14 of their products.
The Supreme Court court had rejected the "unconditional and unqualified apology" tendered by Ramdev and Balkrishna and took strong exception over the violation of the undertaking given to the apex court in November last year.
Patanjali had earlier assured the top court that it would not make any casual statements claiming the medicinal efficacy of its products or advertise or brand them in violation of law and would not release any statement against any system of medicine to the media in any form.
The Supreme Court also took note of the apology issued by Indian Medical Association (IMA) President Dr R.V. Asokan in the IMA's monthly magazine and official website for his statement terming the oral observations made by the apex court during Patanjali misleading advertisements case against allopathy practitioners as "unfortunate" and a "very vague and general statement which has demoralised the doctors".
